271 related articles for article (PubMed ID: 37487086)
1. An activator of voltage-gated K
Servettini I; Talani G; Megaro A; Setzu MD; Biggio F; Briffa M; Guglielmi L; Savalli N; Binda F; Delicata F; Bru-Mercier G; Vassallo N; Maglione V; Cauchi RJ; Di Pardo A; Collu M; Imbrici P; Catacuzzeno L; D'Adamo MC; Olcese R; Pessia M
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2207978120. PubMed ID: 37487086
[TBL] [Abstract][Full Text] [Related]
2. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
Imbrici P; D'Adamo MC; Kullmann DM; Pessia M
Eur J Neurosci; 2006 Dec; 24(11):3073-83. PubMed ID: 17156368
[TBL] [Abstract][Full Text] [Related]
3. A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.
Imbrici P; Altamura C; Gualandi F; Mangiatordi GF; Neri M; De Maria G; Ferlini A; Padovani A; D'Adamo MC; Nicolotti O; Pessia M; Conte D; Filosto M; Desaphy JF
Mol Cell Neurosci; 2017 Sep; 83():6-12. PubMed ID: 28666963
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in
Lauxmann S; Sonnenberg L; Koch NA; Bosselmann C; Winter N; Schwarz N; Wuttke TV; Hedrich UBS; Liu Y; Lerche H; Benda J; Kegele J
Front Neurol; 2021; 12():703970. PubMed ID: 34566847
[No Abstract] [Full Text] [Related]
5. Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature.
Brunetti O; Imbrici P; Botti FM; Pettorossi VE; D'Adamo MC; Valentino M; Zammit C; Mora M; Gibertini S; Di Giovanni G; Muscat R; Pessia M
Neurobiol Dis; 2012 Sep; 47(3):310-21. PubMed ID: 22609489
[TBL] [Abstract][Full Text] [Related]
6. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
Ishida S; Sakamoto Y; Nishio T; Baulac S; Kuwamura M; Ohno Y; Takizawa A; Kaneko S; Serikawa T; Mashimo T
Brain Res; 2012 Jan; 1435():154-66. PubMed ID: 22206926
[TBL] [Abstract][Full Text] [Related]
7. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
Manville RW; Abbott GW
J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
[TBL] [Abstract][Full Text] [Related]
8. Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.
Imbrici P; D'Adamo MC; Grottesi A; Biscarini A; Pessia M
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1314-22. PubMed ID: 21307345
[TBL] [Abstract][Full Text] [Related]
9. A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.
Imbrici P; Gualandi F; D'Adamo MC; Masieri MT; Cudia P; De Grandis D; Mannucci R; Nicoletti I; Tucker SJ; Ferlini A; Pessia M
Neuroscience; 2008 Dec; 157(3):577-87. PubMed ID: 18926884
[TBL] [Abstract][Full Text] [Related]
10. A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.
Zhao J; Petitjean D; Haddad GA; Batulan Z; Blunck R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066705
[TBL] [Abstract][Full Text] [Related]
11. Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.
D'Adamo MC; Liantonio A; Rolland JF; Pessia M; Imbrici P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331416
[TBL] [Abstract][Full Text] [Related]
12. Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.
Imbrici P; D'Adamo MC; Cusimano A; Pessia M
Am J Physiol Cell Physiol; 2007 Feb; 292(2):C778-87. PubMed ID: 16956965
[TBL] [Abstract][Full Text] [Related]
13. Identification of a New
Karalok ZS; Megaro A; Cenciarini M; Guven A; Hasan SM; Taskin BD; Imbrici P; Ceylaner S; Pessia M; D'Adamo MC
Front Neurol; 2018; 9():587. PubMed ID: 30140249
[TBL] [Abstract][Full Text] [Related]
14. The episodic ataxia type 1 mutation I262T alters voltage-dependent gating and disrupts protein biosynthesis of human Kv1.1 potassium channels.
Chen SH; Fu SJ; Huang JJ; Tang CY
Sci Rep; 2016 Jan; 6():19378. PubMed ID: 26778656
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function.
D'Adamo MC; Imbrici P; Sponcichetti F; Pessia M
FASEB J; 1999 Aug; 13(11):1335-45. PubMed ID: 10428758
[TBL] [Abstract][Full Text] [Related]
16. Episodic ataxia/myokymia mutations functionally expressed in the Shaker potassium channel.
Boland LM; Price DL; Jackson KA
Neuroscience; 1999; 91(4):1557-64. PubMed ID: 10391459
[TBL] [Abstract][Full Text] [Related]
17. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.
Eunson LH; Rea R; Zuberi SM; Youroukos S; Panayiotopoulos CP; Liguori R; Avoni P; McWilliam RC; Stephenson JB; Hanna MG; Kullmann DM; Spauschus A
Ann Neurol; 2000 Oct; 48(4):647-56. PubMed ID: 11026449
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.
Zuberi SM; Eunson LH; Spauschus A; De Silva R; Tolmie J; Wood NW; McWilliam RC; Stephenson JB; Kullmann DM; Hanna MG
Brain; 1999 May; 122 ( Pt 5)():817-25. PubMed ID: 10355668
[TBL] [Abstract][Full Text] [Related]
19. Basket to Purkinje Cell Inhibitory Ephaptic Coupling Is Abolished in Episodic Ataxia Type 1.
Martin HGS; Kullmann DM
Cells; 2023 May; 12(10):. PubMed ID: 37408217
[TBL] [Abstract][Full Text] [Related]
20. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
Browne DL; Gancher ST; Nutt JG; Brunt ER; Smith EA; Kramer P; Litt M
Nat Genet; 1994 Oct; 8(2):136-40. PubMed ID: 7842011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
